NASDAQ · PYPD
PolyPid financials
$5.29−0.38%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Gross margin | — | — | — | — | — | — |
| Operating income | -$33.0M | -$28.0M | -$22.9M | -$38.9M | -$43.1M | -$26.3M |
| Net income | -$34.2M | -$29.0M | -$23.9M | -$39.6M | -$42.6M | -$42.9M |
| Net margin | — | — | — | — | — | — |
| Diluted EPS | $-2.09 | $-4.91 | $-16.93 | $-61.09 | $-68.27 | $-4.48 |
| EBITDA | -$31.5M | -$26.4M | -$21.0M | -$38.9M | -$42.0M | -$25.3M |
| Operating cash flow | -$27.9M | -$22.0M | -$17.2M | -$34.3M | -$32.4M | -$21.6M |
| Free cash flow | -$28.1M | -$22.0M | -$17.4M | -$36.1M | -$35.4M | -$22.8M |
| Diluted shares | 16.4M | 5.9M | 1.4M | 0.6M | 0.6M | 9.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.4M | $15.6M | $5.3M | $8.6M | $9.8M | $4.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | $40.2M |
| Total debt | $988.0K | $7.4M | $10.4M | $11.6M | $0.00 | $0.00 |
| Total assets | $22.3M | $25.2M | $15.4M | $26.0M | $44.2M | $75.8M |
| Total liabilities | $11.3M | $17.5M | $17.5M | $20.1M | $8.3M | $3.1M |
| Shareholders' equity | $11.0M | $7.7M | -$2.1M | $5.8M | $36.0M | $72.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology